MIAMI--(BUSINESS WIRE)--May 1, 2006--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN - News), a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products, today announced financial results for the first quarter of 2006.
